ES2059129T3 - Procedimiento para la produccion de plasma sanguineo no infeccioso. - Google Patents

Procedimiento para la produccion de plasma sanguineo no infeccioso.

Info

Publication number
ES2059129T3
ES2059129T3 ES91906410T ES91906410T ES2059129T3 ES 2059129 T3 ES2059129 T3 ES 2059129T3 ES 91906410 T ES91906410 T ES 91906410T ES 91906410 T ES91906410 T ES 91906410T ES 2059129 T3 ES2059129 T3 ES 2059129T3
Authority
ES
Spain
Prior art keywords
blood plasma
procedure
production
infectious blood
infectious
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91906410T
Other languages
English (en)
Spanish (es)
Inventor
Dieter Wolter
Horst Schwinn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New York Blood Center Inc
Original Assignee
New York Blood Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6402597&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2059129(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by New York Blood Center Inc filed Critical New York Blood Center Inc
Application granted granted Critical
Publication of ES2059129T3 publication Critical patent/ES2059129T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES91906410T 1990-03-20 1991-03-16 Procedimiento para la produccion de plasma sanguineo no infeccioso. Expired - Lifetime ES2059129T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4008852A DE4008852A1 (de) 1990-03-20 1990-03-20 Verfahren zur herstellung von nicht-infektioesem blutplasma

Publications (1)

Publication Number Publication Date
ES2059129T3 true ES2059129T3 (es) 1994-11-01

Family

ID=6402597

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91906410T Expired - Lifetime ES2059129T3 (es) 1990-03-20 1991-03-16 Procedimiento para la produccion de plasma sanguineo no infeccioso.

Country Status (8)

Country Link
EP (1) EP0472708B1 (enExample)
JP (1) JP2708632B2 (enExample)
AT (1) ATE110272T1 (enExample)
DE (3) DE4008852A1 (enExample)
DK (1) DK0472708T3 (enExample)
ES (1) ES2059129T3 (enExample)
FI (1) FI101128B (enExample)
WO (1) WO1991014439A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2180328A1 (en) * 1994-01-10 1995-07-13 Franco Castino Device and process for removing leukocytes and viral inactivating agents from blood
US5639376A (en) * 1994-01-10 1997-06-17 Hemasure, Inc. Process for simultaneously removing leukocytes and methylene blue from plasma
US6136865A (en) * 1995-05-20 2000-10-24 Octapharma Ag Method for reduction of the infectiousness of potentially infectious material
DE19729778A1 (de) * 1997-07-11 1999-01-21 Blutspendedienst Der Drk Lande Verfahren zur Herstellung von virusinaktivierten biologischen Flüssigkeiten
EP0896824A1 (en) † 1997-08-05 1999-02-17 Octapharma Ag A universally applicable blood plasma
US7655252B2 (en) 1999-04-28 2010-02-02 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
US6635676B2 (en) * 1999-04-28 2003-10-21 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
JP2010209109A (ja) * 2001-06-25 2010-09-24 Regents Of The Univ Of Michigan 抗微生物ナノエマルジョンの組成物および方法
CN1302009C (zh) * 2005-09-05 2007-02-28 武汉海特生物制药股份有限公司 用有机溶剂病毒灭活法制备鼠神经生长因子的工艺
EP2152304B1 (en) 2007-05-02 2018-08-22 The Regents of the University of Michigan Nanoemulsion therapeutic compositions and methods of using the same
EP2034010A1 (en) 2007-08-30 2009-03-11 Omrix Biopharmaceuticals Ltd. Compositions suitable for repair and/or treatment of injured spinal tissue
EP2376089B1 (en) 2008-11-17 2018-03-14 The Regents of the University of Michigan Cancer vaccine compositions and methods of using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3033932C2 (de) * 1980-09-10 1984-05-24 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Kaltsterilisation von Blutgerinnungsfaktor VIII enthaltenden Präparaten
EP0050061B2 (en) * 1980-10-06 1990-06-20 New York Blood Center, Inc. Method of reducing undesirable activities of biological and pharmaceutical products
US4591505A (en) * 1982-04-14 1986-05-27 New York Blood Center, Inc. Process for inactivating hepatitis B virus
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US4789545A (en) * 1986-03-31 1988-12-06 New York Blood Center, Inc. Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof
US5094960A (en) * 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
ATE85221T1 (de) * 1988-11-05 1993-02-15 Octapharma Ag Verfahren zur herstellung eines hochreinen, nicht infektioesen antihaemophiliefaktors mittels chromatographie.

Also Published As

Publication number Publication date
EP0472708A1 (de) 1992-03-04
FI915301A0 (fi) 1991-11-11
DE4008852A1 (de) 1991-09-26
JP2708632B2 (ja) 1998-02-04
DE4021542C2 (de) 1995-08-17
DE59102623D1 (de) 1994-09-29
DK0472708T3 (da) 1994-09-19
EP0472708B1 (de) 1994-08-24
DE4008852C2 (enExample) 1992-06-17
WO1991014439A1 (de) 1991-10-03
ATE110272T1 (de) 1994-09-15
FI101128B (fi) 1998-04-30
DE4021542A1 (de) 1992-01-09
JPH04506668A (ja) 1992-11-19

Similar Documents

Publication Publication Date Title
ES2059129T3 (es) Procedimiento para la produccion de plasma sanguineo no infeccioso.
ES2000428A4 (es) Procedimiento para producir un medicamento para el tratamiento de la enfermedad de alzheimer, que contiene galantamina, y dispositivo medico correspondiente.
ZA908525B (en) A process for the production of isoflavones
NO975387D0 (no) Fremgangsmåte for fremstilling av 3-haloalkyl-1H-pyrazoler
IT1194645B (it) Processo per il trattamento di peci nella produzione di manufatti a base di carbonio
ES2005889A6 (es) Un metodo con su aparato correspondiente para la produccion de peliculas perforadas
DE69129800D1 (de) Behandlung von menschlichen retrovirus-infektionen mit 2',3'-dideoxyinosin
FR2703263B1 (fr) Procédé de préparation de sphérules de principes actifs.
NZ236415A (en) Gelatin treated polyhydric alcohol based carrier, method of producing the carrier and lozenges comprising the above carrier
ES2022464B3 (es) Proceso y aparato para producir una ebullicion multizona.
NO875286D0 (no) Fremgangsmaate for replikering av benmarg.
FR2643657B1 (fr) Tissu tridimensionnel et procede pour sa fabrication
EP0366865A3 (en) Method for implementing a combining switch for support parallel processing
EP0269009A3 (en) Method for the production of carbinol derivatives
FR2623805B1 (fr) Procede de preparation de la vitamine a
HUT58751A (en) Process for producing antiarthritic geminal diphosphonic acids and derivatives
DE3786515D1 (de) Verfahren zum herstellen von augenprothesen, sklerotischen linsen und kontaktlinsen, sowie nach dem verfahren hergestellte gegenstaende.
ES2130632T3 (es) Purificacion de cloruro de alilo.
ES2062765T3 (es) Procedimiento para la preparacion de l-alfa-glicerilfosforil-d-mioinositol y sus sales.
ES2071081T3 (es) Liposomas fosfolipidicos que contienen principios activos y un procedimiento para su obtencion.
IL82937A (en) 4-benzoyloxy-3-pyrrolin-2-on-1-yl acetamide,process for the preparation thereof and the use thereof
FI100769B (fi) Menetelmä triglyseridejä sisältävän farmaseuttisen podofyllotoksiiniva lmisteen valmistamiseksi
ES2068425T3 (es) Procedimiento para la preparacion de compuestos de 2-aril-5-(trifluormetil)pirrol insecticidas, acaricidas y nematicidas.
MX9800243A (es) Procedimiento para producir principios activos a partir de dispositivos no usados o descartados para la administracion transdermica de principios actios y/o a partir de desechos de fabricacion.
DE69005113D1 (de) Verwendung von peroxidlipiden zur herstellung eines arzneimittels zur behandlung von kreislaufinsuffizienz bei lokaler applikation.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 472708

Country of ref document: ES